期刊文献+

儿童伴血小板生长因子受体β基因重排的髓系肿瘤急变为急性淋巴细胞白血病一例报告附文献复习

原文传递
导出
摘要 伴血小板生长因子受体β(PDGFRβ)基因重排的髓系肿瘤是一种较罕见的血液系统肿瘤,以髓系增生异常、嗜酸粒细胞增多、PDGFRβ基因重排为主要特征。此肿瘤最常见的染色体易位为t(5;12)(q33;p13),导致位于5号染色体的PDGFRβ基因与12号染色体短臂的TEL基因并置,
出处 《中华血液学杂志》 CAS CSCD 北大核心 2011年第12期871-873,共3页 Chinese Journal of Hematology
  • 相关文献

参考文献14

  • 1Proven D,Singer C R J,Baglin T,et al.牛津临床血液病手册.黄晓军,译.北京:人民卫生出版社,2006:191-193.
  • 2Bain BJ. Leukaemia diagnosis. 4th ed. Oxford: Witey-Blackwell, 2010 : 279-281.
  • 3Steer E J, Cross NC. Myeloproliferative disorders with translocation of chromosomes 5q31-35: role of the platelet-derived growth factor receptor beta. Acta Haematol, 2002, 107 :113-122.
  • 4张艳,何琦,黄晓军,江浩,杨申淼,路瑾,秦亚溱,师岩,党辉,邱镜滢,陆道培.嗜酸性粒细胞增多症的细胞遗传学研究[J].中国实验血液学杂志,2007,15(3):454-457. 被引量:10
  • 5Wittman B, Horan J, Baxter J, et al. A 2-year-old with atypical CML with a t(5 ; 12) ( q33 ; p13 ) treated successfully with imatinib mesylate. Leuk Res, 2004, 28 Suppl 1: 65-69.
  • 6龚胜蓝,邱慧颖,宋献民,邵宇,王健民.伴有PDGFRβ基因异常的骨髓增生异常/增殖性肿瘤综合征的临床和实验研究[J].中华血液学杂志,2010,31(8):540-544. 被引量:4
  • 7Xin H, Medeiros J, Abruzzo LV, et al. Chronic myeloproliferative diseases with the t(5 ; 12 ) ( q33 ; p13 ). Am J Clin Pathol, 2006, 125 : 49-56.
  • 8Bain BJ. Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRa, PDGFRI3or FGFR1. Haematologica, 2010, 95: 696-698.
  • 9Rodig SJ, Kutok JL. Bone marrow disorders with associated eosino- philia. Diagnostic Histopathology, 2009, 15: 107-115.
  • 10Galimberti S, Ferreri MI, Simi P, et al. Platelet-derived growth factor beta receptor (PDGFRβ) gene is rearranged in a significant percentage of myelodysplastic syndromes with normal karyotype. Br J Haematol, 2009, 147: 763-766.

二级参考文献23

  • 1秦亚溱,阮国瑞,李金兰,付家瑜,常艳,王卉,李玲娣,刘艳荣,陈珊珊.定量检测WT1基因表达水平在急性髓系白血病微量残留病监测中的意义[J].中华血液学杂志,2005,26(11):649-652. 被引量:22
  • 2Song X,Gong S,Yang J,et al.Clinical and molecular cytogenetic characteristics of dic(9 ;20) in adult acute lymphoblastic leukemia:a case report of three patients.Ann Hematol,2007,86:347-351.
  • 3Cools J,DeAngelo DJ,Gotlib J,et al.A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.N Engl J Med,2003,348:1201-1214.
  • 4Cross NCP,Reiter A.Tyrosine kinase fusion genes in chronic myeloproliferative diseases.Leukemia,2002,16:1207-1212.
  • 5Vardiman JW,Thiele J,Arber D,et al.The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia:rationale and important changes.Blood,2009,114:937-951.
  • 6Steer EJ,Cross NC.Myeloproliferative disorders with translocations of chromosome 5q31 -q35:role of the platelet-derived growth factor receptor Beta.Acta Haematol,2002,107:113-122.
  • 7Walz C,Metzgeroth G,Haferlach C,et al.Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta gene.Haematologica,2007,92:163-169.
  • 8Galimberti S,Ferreri MI,Simi P,et al.Platelet-derived growth factor beta receptor (PDGFRB) gene is rearranged in a significant percentage of myelodysplastic syndromes with normal karyotype.Br J Haematol,2009,147:763-766.
  • 9Nadal N,Flandrin P,Cornillon J,et al.Successful treatment with imatinib mesylate in a case of chronic myeloproliferative disorder with a t (5; 12) (q33; p13.1) without eosinophilia.Cancer Genet Cytogenet,2006,169:174-175.
  • 10Golub TR,Barker GF,Lovett M,et al.Fusion of PDGF receptor beta to a novel ets-like gene,tel,in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.Cell,1994,77:307-316.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部